Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.
about
Tigecycline: a review of a new glycylcycline antibioticPharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy SubjectsEffects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjects.Evaluation of a potential tigecycline-warfarin drug interaction.Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia.Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria.Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.Tigecycline: a new glycylcycline for treatment of serious infections.High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.Tigecyclin--the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline.Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline.Tigecycline for the treatment of infections due to resistant Gram-positive organisms.Tigecycline: a novel glycylcycline antibiotic.In Vitro Activity of Tigecycline Against Orientia tsutsugamushi.Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.A review of tigecycline.Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.Tigecycline as a Second-Line Agent for Legionnaires' Disease in Severely Ill PatientsIn vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
P2860
Q28278979-9069A2CF-405C-43B2-BB0B-A34E7615D534Q29398341-5E235D3F-C0D6-4C00-B173-D9A0B74E31C1Q33722140-147CC85D-BA70-4229-A937-CDF0B4D5A4C0Q34593514-6C79A638-D3FB-45A0-B24B-4CAA64E879EBQ35026616-D3E058CE-B9C7-4982-AF63-F74B8DA5417AQ35637071-30BF1D93-4DA5-4043-9C4C-4F1539C4D9BBQ35758970-276A669C-C1F7-46EC-B218-A2C66572A369Q36218312-CD4B1B47-0986-428E-B868-FAD3136FB7A9Q36290493-E388848C-5C42-4C58-A890-D97D795C06E4Q36312068-A4F77A4D-E3C9-429C-BCD5-DC67712325AFQ36312071-4AB896BD-AED8-4E6C-BDCB-EB513B697FDBQ36376443-5DAB2922-B666-45F2-B2C5-9F80F4BE3B79Q36379330-1D23470C-C804-4C76-B4DF-C435DD64945DQ37110121-DE8E431E-A934-4C4B-A7F8-0708CA84ADFCQ37204133-B7657F77-F2F0-4A18-87EB-0C8573479C77Q37335695-730FCED6-8331-4D56-894D-D7F7C1AC5FEEQ37608268-31EF0F6A-04E6-4F0A-8CF5-655B6C5D8F90Q42270776-982E46D8-B360-417F-9CF6-E01E90761073Q42839586-3E1C1023-13A7-4A12-821A-C3214DA1B51F
P2860
Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Activities of tigecycline (GAR ...... with L. pneumophila pneumonia.
@en
Activities of tigecycline
@nl
type
label
Activities of tigecycline (GAR ...... with L. pneumophila pneumonia.
@en
Activities of tigecycline
@nl
prefLabel
Activities of tigecycline (GAR ...... with L. pneumophila pneumonia.
@en
Activities of tigecycline
@nl
P2093
P2860
P1476
Activities of tigecycline (GAR ...... with L. pneumophila pneumonia.
@en
P2093
Martha A C Edelstein
Paul H Edelstein
William J Weiss
P2860
P304
P356
10.1128/AAC.47.2.533-540.2003
P407
P577
2003-02-01T00:00:00Z